Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study
Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study
Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study